Logo

Specialty Labs and Tm Make Available CF Screening Test

Nov 26, 2003

NEW YORK, Nov. 26 (GenomeWeb News) -Specialty Laboratories and Tm biosciences today announced the availability of a multiplex genetic screening test for Cystic Fibrosis that they have jointly developed.

 

The test screens for 70 of the most clinically important CF gene mutations in the US population. The test is based on Tm's Tag-it mutation detection technology, and is being made available through physicians and other health care professionals.

 

Breaking News
The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.